Skip to main content

Equibles does not estimate personal net worth.

About Amanda Hammer

Amanda Hammer is recorded as COO at Mangoceuticals, Inc. (MGRX) since May 1, 2023 and Board Member at Mangoceuticals, Inc. (MGRX). The newest filing on record that lists Amanda Hammer as Board Member at Mangoceuticals, Inc. (MGRX) is dated May 16, 2024. Mangoceuticals, Inc. reported in an 8-K filed October 29, 2025 that Amanda Hammer was terminated as Employee, effective October 22, 2025. Mangoceuticals, Inc. reported in an 8-K filed October 29, 2025 that Amanda Hammer was terminated as Chief Operating Officer, effective October 22, 2025. Mangoceuticals, Inc. reported in an 8-K filed May 4, 2023 that Amanda Hammer was appointed Chief Operating Officer, effective May 4, 2023. Equibles holds 4 filed executive changes naming Amanda Hammer; each is listed under recent activity with its source filing. The proxy statement of Mangoceuticals, Inc. reports total compensation of $329,431 for Amanda Hammer in fiscal 2023, including a base salary of $105,417. Mangoceuticals, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Mangoceuticals, Inc. includes Josef Freundorfer (CEO), Sagar Sanghera (Chairman and Board Member), Eugene M. Johnston (CFO and Board Member) and 6 others.

“Employee's Employment with Employer terminated as of October 22, 2025 (the "Separation Date"), on the terms and conditions set forth herein.”
Mangoceuticals, Inc. Form 8-K, filed October 29, 2025 · Read the filing
“On October 27, 2025, the Company entered into a Separation Agreement with its then Chief Operating Officer, Amanda Hammer, pursuant to which (i) Hammer's employment with the Company was terminated, effective October 22, 2025”
Mangoceuticals, Inc. Form 8-K, filed October 29, 2025 · Read the filing

Affiliation history

Company network

Current role

Health Information Services · Healthcare

Board Member, COO

2023-05-01–present

Leadership on record at Mangoceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Mangoceuticals, Inc. (MGRX) $105,417 $329,431

Recent activity